Current Status of Radiopharmaceuticals for the Theranostics of Neuroendocrine Neoplasms

Por Fani, Melpomeni, Kolenc Peitl, Petra, Velikyan, Irina
Publicado no Pharmaceuticals (Basel) (2017)

Preoperative Glucagon-like peptide-1 receptor imaging reduces surgical trauma and pancreatic tissue loss in insulinoma patients: a report of three cases

Por Wenning, Anna Silvia, Kirchner, Paul, Antwi, Kwadwo, Fani, Melpomeni, Wild, Damian, Christ, Emanuel, Gloor, Beat
Publicado no Patient Saf Surg (2015)

The somatostatin receptor 2 antagonist (64)Cu-NODAGA-JR11 outperforms (64)Cu-DOTA-TATE in a mouse xenograft model

Por Rylova, Svetlana N., Stoykow, Christian, Del Pozzo, Luigi, Abiraj, Keelara, Tamma, Maria Luisa, Kiefer, Yvonne, Fani, Melpomeni, Maecke, Helmut R.
Publicado no PLoS One (2018)

The tetraamine chelator outperforms HYNIC in a new technetium-99m-labelled somatostatin receptor 2 antagonist

Por Abiraj, Keelara, Ursillo, Samer, Tamma, Maria Luisa, Rylova, Svetlana N., Waser, Beatrice, Constable, Edwin C., Fani, Melpomeni, Nicolas, Guillaume P., Reubi, Jean Claude, Maecke, Helmut R.
Publicado no EJNMMI Res (2018)